David L. Aylor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
David L. Aylor has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Samuel J. Widmayer
Genomic Medicine, The Jackson Laboratory, Farmington, CT, USA
4 shared publications - Douglas A. Marchuk
Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, USA
3 shared publications - Han Kyu Lee
Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC (H.K.L., D.A.M.).
3 shared publications - Heather B. Patisaul
North Carolina State University
3 shared publications - Bo Zhang
Department of Developmental Biology, Washington University School of Medicine, St. Louis, USA
2 shared publications - Cheryl Lyn Walker
Center for Precision Environmental Health, Baylor College of Medicine
2 shared publications
Latest Publications
- Open Access
- 9 April 2026
- Published by Elsevier in Current Opinion in Neurobiology
- Vol. 98, 103192
Understanding the contribution of toxicant exposures to Alzheimer’s disease and related dementias
- 9 April 2026
- Published by Elsevier in Current Opinion in Neurobiology
- Vol. 98, 103192
Open AccessUnderstanding the contribution of toxicant exposures to Alzheimer’s disease and related dementias
- Open Access
Inferring toxicant susceptibility in global populations from gene-environment interactions involving the Aryl Hydrocarbon Receptor
Gene-environment interaction (GxE) studies comprise a very small part of the genetics or environmental epidemiology literature, and most existing studies are in populations of European ancestry. We made predictions about GxE in global populations by combining existing GxE studies with genetic data from the 1000 Genomes Project (1kGP), which captured genetic variation in diverse populations worldwide. We modeled susceptibility of 1kGP populations to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) exposures based on variation in the aryl hydrocarbon receptor ( AHR ) gene. The premise of our approach is that the risk variants involved in GxE are shared across global super-populations but vary in frequency by population. We built our model upon GxE estimates from a study in Seveso, Italy, where offspring birthweight was influenced by AHR variants after TCDD exposure. Our simulations predicted that GxE would result in different outcomes across global populations. This framework can be extended to model population susceptibility to a broad range of toxicants that impact public health, including common AHR ligands like the polycyclic aromatic hydrocarbons found in cigarette smoke and diesel exhaust.
Open AccessInferring toxicant susceptibility in global populations from gene-environment interactions involving the Aryl Hydrocarbon Receptor
Gene-environment interaction (GxE) studies comprise a very small part of the genetics or environmental epidemiology literature, and most existing studies are in populations of European ancestry. We made predictions about GxE in global populations by combining existing GxE studies with genetic data from the 1000 Genomes Project (1kGP), which captured genetic variation in diverse populations worldwide. We modeled susceptibility of 1kGP populations to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) exposures based on variation in the aryl hydrocarbon receptor ( AHR ) gene. The premise of our approach is that the risk variants involved in GxE are shared across global super-populations but vary in frequency by population. We built our model upon GxE estimates from a study in Seveso, Italy, where offspring birthweight was influenced by AHR variants after TCDD exposure. Our simulations predicted that GxE would result in different outcomes across global populations. This framework can be extended to model population susceptibility to a broad range of toxicants that impact public health, including common AHR ligands like the polycyclic aromatic hydrocarbons found in cigarette smoke and diesel exhaust.
- Open Access
- 10 October 2025
- Published by Springer Nature in Research Square
Cross-tissue molecular responses in the liver and blood after toxicant exposures
Exposure to toxic substances, particularly early in life, can perturb epigenomic marks linked to disease susceptibility. Human studies of environmental exposures often rely on surrogate tissues such as blood, but toxicant accumulation differs across organs and results in tissue-specific responses. Thus, understanding whether exposure-induced epigenomic alterations in surrogate tissues such as blood reflect changes in toxicant target tissues, such as liver, is essential for designing and interpreting environmental epigenetic studies. To address this knowledge gap, we systematically analyzed 1,013 multi-omics data from the TaRGET II Consortium, comparing molecular responses in mouse liver and blood following perinatal exposure to arsenic, lead, bisphenol A, tributyltin, di-2-ethylhexyl phthalate, tetrachlorodibenzo-p-dioxin, or air pollution in the form of particulate matter < 2.5µm (PM2.5). Most toxicant-induced molecular changes were tissue-specific, yet we identified a subset of co-regulated genes and regulatory elements in liver and blood in response to early-life exposure to toxicants. Moreover, we discovered that specific pathways, such as immune-related processes, were commonly affected by exposures in both tissues, and transcription factors, including Klf, Jun, Ets1, and Cebp, emerged as shared regulators. While molecular alterations are infrequently conserved between tissues following toxicant exposure, the shared alterations in transcription factors and biological pathways may provide a strategy to link effects in surrogate tissues to target tissues.
- 10 October 2025
- Published by Springer Nature in Research Square
Open AccessCross-tissue molecular responses in the liver and blood after toxicant exposures
Exposure to toxic substances, particularly early in life, can perturb epigenomic marks linked to disease susceptibility. Human studies of environmental exposures often rely on surrogate tissues such as blood, but toxicant accumulation differs across organs and results in tissue-specific responses. Thus, understanding whether exposure-induced epigenomic alterations in surrogate tissues such as blood reflect changes in toxicant target tissues, such as liver, is essential for designing and interpreting environmental epigenetic studies. To address this knowledge gap, we systematically analyzed 1,013 multi-omics data from the TaRGET II Consortium, comparing molecular responses in mouse liver and blood following perinatal exposure to arsenic, lead, bisphenol A, tributyltin, di-2-ethylhexyl phthalate, tetrachlorodibenzo-p-dioxin, or air pollution in the form of particulate matter < 2.5µm (PM2.5). Most toxicant-induced molecular changes were tissue-specific, yet we identified a subset of co-regulated genes and regulatory elements in liver and blood in response to early-life exposure to toxicants. Moreover, we discovered that specific pathways, such as immune-related processes, were commonly affected by exposures in both tissues, and transcription factors, including Klf, Jun, Ets1, and Cebp, emerged as shared regulators. While molecular alterations are infrequently conserved between tissues following toxicant exposure, the shared alterations in transcription factors and biological pathways may provide a strategy to link effects in surrogate tissues to target tissues.
- Open Access
- 20 August 2025
- Published by Springer Nature in Research Square
Toxicogenomic Insights into Environmental Toxicant Exposures: The TaRGET II Resource
Environmental exposures to toxic chemicals can profoundly alter the transcriptome and epigenome in both humans and animals, contributing to disease development across the lifespan. To elucidate how early-life exposure to toxicants exerts such persistent effects, the Toxicant Exposures and Responses by Genomic and Epigenomic Regulators of Transcription II (TaRGET II) Consortium generated a landmark resource comprising 2,570 epigenomes and 1,043 transcriptomes from longitudinal studies in mice. All data are publicly available through the TaRGET II data portal and the WashU Epigenome Browser. This resource from target (liver, brain, lung, heart) and surrogate (blood) tissues at weaning (3 weeks) and two adult time-points (5 and 10 months) characterized the molecular response to arsenic (As), lead (Pb), bisphenol-A (BPA), di-2-ethylhexyl phthalate(DEHP), tributyltin (TBT), tetrachlorodibenzo-p-dioxin (TCDD), and particulate matter with a diameter of <2.5μm (PM2.5). The findings revealed persistent, toxicant-specific, sex-dependent epigenomic and transcriptomic perturbations, resulting in disrupted expression of 14,908 genes, altered chromatin accessibility at 87,409 regulatory elements, DNA methylation changes at 113,186 genomic regions, and chromatin state switching of histone modifications. The resulting high-resolution map of how environmental exposures reprogram the epigenome and transcriptome is broadly accessible via ToxiTaRGET database, offering unparalleled opportunities for the scientific community to investigate the molecular underpinnings of environmental toxicant exposures and their contributions to disease pathogenesis.
- 20 August 2025
- Published by Springer Nature in Research Square
Open AccessToxicogenomic Insights into Environmental Toxicant Exposures: The TaRGET II Resource
Environmental exposures to toxic chemicals can profoundly alter the transcriptome and epigenome in both humans and animals, contributing to disease development across the lifespan. To elucidate how early-life exposure to toxicants exerts such persistent effects, the Toxicant Exposures and Responses by Genomic and Epigenomic Regulators of Transcription II (TaRGET II) Consortium generated a landmark resource comprising 2,570 epigenomes and 1,043 transcriptomes from longitudinal studies in mice. All data are publicly available through the TaRGET II data portal and the WashU Epigenome Browser. This resource from target (liver, brain, lung, heart) and surrogate (blood) tissues at weaning (3 weeks) and two adult time-points (5 and 10 months) characterized the molecular response to arsenic (As), lead (Pb), bisphenol-A (BPA), di-2-ethylhexyl phthalate(DEHP), tributyltin (TBT), tetrachlorodibenzo-p-dioxin (TCDD), and particulate matter with a diameter of <2.5μm (PM2.5). The findings revealed persistent, toxicant-specific, sex-dependent epigenomic and transcriptomic perturbations, resulting in disrupted expression of 14,908 genes, altered chromatin accessibility at 87,409 regulatory elements, DNA methylation changes at 113,186 genomic regions, and chromatin state switching of histone modifications. The resulting high-resolution map of how environmental exposures reprogram the epigenome and transcriptome is broadly accessible via ToxiTaRGET database, offering unparalleled opportunities for the scientific community to investigate the molecular underpinnings of environmental toxicant exposures and their contributions to disease pathogenesis.
- 8 September 2022
- Published by S. Karger AG in Neuroendocrinology
- Vol. 113  (12) , 1262-1282
Impacts of Gestational FireMaster 550 Exposure on the Neonatal Cortex Are Sex Specific and Largely Attributable to the Organophosphate Esters
Introduction: Flame retardants (FRs) are common bodily and environmental pollutants, creating concern about their potential toxicity. We and others have found that the commercial mixture FireMaster® 550 (FM 550) or its individual brominated (BFR) and organophosphate ester (OPFR) components are potential developmental neurotoxicants. Using Wistar rats, we previously reported that developmental exposure to FM 550 or its component classes produced sex- and compound-specific effects on adult socioemotional behaviors. The underlying mechanisms driving the behavioral phenotypes are unknown. Methods: To further mechanistic understanding, here we conducted transcriptomics in parallel with a novel lipidomics approach using cortical tissues from newborn siblings of the rats in the published behavioral study. Inclusion of lipid composition is significant because it is rarely examined in developmental neurotoxicity studies. Pups were gestationally exposed via oral dosing to the dam to FM 550 or the BFR or OPFR components at environmentally relevant doses. Results: The neonatal cortex was highly sexually dimorphic in lipid and transcriptome composition, and males were more significantly impacted by FR exposure. Multiple adverse modes of action for the BFRs and OPFRs on neurodevelopment were identified, with the OPFRs being more disruptive than the BFRs via multiple mechanisms including dysregulation of mitochondrial function and disruption of cholinergic and glutamatergic systems. Disrupted mitochondrial function by environmental factors has been linked to a higher risk of autism spectrum disorders and neurodegenerative disorders. Impacted lipid classes included ceramides, sphingomyelins, and triacylglycerides. Robust ceramide upregulation in the OPFR females could suggest a heightened risk of brain metabolic disease. Conclusions: This study reveals multiple mechanisms by which the components of a common FR mixture are developmentally neurotoxic and that the OPFRs may be the compounds of greatest concern.
- 8 September 2022
- Published by S. Karger AG in Neuroendocrinology
- Vol. 113  (12) , 1262-1282
Impacts of Gestational FireMaster 550 Exposure on the Neonatal Cortex Are Sex Specific and Largely Attributable to the Organophosphate Esters
Introduction: Flame retardants (FRs) are common bodily and environmental pollutants, creating concern about their potential toxicity. We and others have found that the commercial mixture FireMaster® 550 (FM 550) or its individual brominated (BFR) and organophosphate ester (OPFR) components are potential developmental neurotoxicants. Using Wistar rats, we previously reported that developmental exposure to FM 550 or its component classes produced sex- and compound-specific effects on adult socioemotional behaviors. The underlying mechanisms driving the behavioral phenotypes are unknown. Methods: To further mechanistic understanding, here we conducted transcriptomics in parallel with a novel lipidomics approach using cortical tissues from newborn siblings of the rats in the published behavioral study. Inclusion of lipid composition is significant because it is rarely examined in developmental neurotoxicity studies. Pups were gestationally exposed via oral dosing to the dam to FM 550 or the BFR or OPFR components at environmentally relevant doses. Results: The neonatal cortex was highly sexually dimorphic in lipid and transcriptome composition, and males were more significantly impacted by FR exposure. Multiple adverse modes of action for the BFRs and OPFRs on neurodevelopment were identified, with the OPFRs being more disruptive than the BFRs via multiple mechanisms including dysregulation of mitochondrial function and disruption of cholinergic and glutamatergic systems. Disrupted mitochondrial function by environmental factors has been linked to a higher risk of autism spectrum disorders and neurodegenerative disorders. Impacted lipid classes included ceramides, sphingomyelins, and triacylglycerides. Robust ceramide upregulation in the OPFR females could suggest a heightened risk of brain metabolic disease. Conclusions: This study reveals multiple mechanisms by which the components of a common FR mixture are developmentally neurotoxic and that the OPFRs may be the compounds of greatest concern.
- Open Access
A neuroprotective locus modulates ischemic stroke infarction independent of collateral vessel anatomy
Ischemic stroke is caused by a disruption of the blood supply to the brain leading to neuronal cell death. Genetic studies of ischemic stroke have identified numerous gene variants that increase the risk to develop stroke. In stark contrast, genetic studies of stroke outcomes, such as the infarct territory size, are confounded by many uncontrollable variables, leading to a paucity of gene targets for treatment of an incipient stroke. Using genetically diverse inbred strains of mice and a surgically-induced model of ischemic stroke, we used quantitative trait locus mapping to identify novel gene targets modulating infarct size, which varies greatly across inbred strains. Although infarct size is largely determined by the extent of collateral vessel connection between arteries in the brain that enables reperfusion of the ischemic territory, we have identified strain pairs that do not vary in this phenotype, but which nonetheless exhibit large differences in infarct size. In this study we performed QTL mapping in mice from an intercross between two such strains, WSB/EiJ and C57BL/6J. We identified a strong locus on chromosome 8 that overlaps with a locus of similar direction and effect previously mapped in an intercross between C3H/HeJ and C57BL/6J strains. To identify causative genes within the overlapping genetic interval, we surveyed nonsynonymous coding SNPs and performed RNA sequencing data analysis for all three mapping strains. We identified Macrophage Scavenger Receptor 1 ( Msr1 ) as a strong candidate gene that harbors multiple coding SNPs predicted to be damaging. Using Msr1 -deficient mice, we demonstrated that cerebral infarct volume after stroke induction is dramatically increased in a strain background where reperfusion effects due to collateral vessels is blunted. Significantly, the identification of neuroprotective genes such as Msr1 provides new genes for future mechanistic studies of infarction following ischemic stroke and provides novel gene/protein targets for therapeutic development. Author summary: The most common form of stroke arises when a blockage occurs in a blood vessel of the brain, thereby preventing delivery of oxygen and nutrients to areas supplied by the affected vessel, leading to tissue death. The main treatment for this form of stroke is medication to dissolve the blockage; however, more treatment options are required to better reduce the death and disability associated with stroke. In this study, we sought to identify genes that can decrease the amount of damage to brain tissue following a stroke, with a specific focus on examining genes that work to directly protect the neurons, rather than returning blood flow to the affected area. Since it is impossible to precisely control the nature of stroke and the genetic variability in humans, we used mice identify a genetic region that is associated with the amount of tissue damage following stroke. Within this genetic region, we identified a list of candidate genes, including the gene Msr1 , which we found is important for controlling tissue damage in one genetic population of mice after stroke. The genes identified here require further follow-up to determine the impact on stroke outcomes and the usefulness of these candidates as therapeutic targets.
Open AccessA neuroprotective locus modulates ischemic stroke infarction independent of collateral vessel anatomy
Ischemic stroke is caused by a disruption of the blood supply to the brain leading to neuronal cell death. Genetic studies of ischemic stroke have identified numerous gene variants that increase the risk to develop stroke. In stark contrast, genetic studies of stroke outcomes, such as the infarct territory size, are confounded by many uncontrollable variables, leading to a paucity of gene targets for treatment of an incipient stroke. Using genetically diverse inbred strains of mice and a surgically-induced model of ischemic stroke, we used quantitative trait locus mapping to identify novel gene targets modulating infarct size, which varies greatly across inbred strains. Although infarct size is largely determined by the extent of collateral vessel connection between arteries in the brain that enables reperfusion of the ischemic territory, we have identified strain pairs that do not vary in this phenotype, but which nonetheless exhibit large differences in infarct size. In this study we performed QTL mapping in mice from an intercross between two such strains, WSB/EiJ and C57BL/6J. We identified a strong locus on chromosome 8 that overlaps with a locus of similar direction and effect previously mapped in an intercross between C3H/HeJ and C57BL/6J strains. To identify causative genes within the overlapping genetic interval, we surveyed nonsynonymous coding SNPs and performed RNA sequencing data analysis for all three mapping strains. We identified Macrophage Scavenger Receptor 1 ( Msr1 ) as a strong candidate gene that harbors multiple coding SNPs predicted to be damaging. Using Msr1 -deficient mice, we demonstrated that cerebral infarct volume after stroke induction is dramatically increased in a strain background where reperfusion effects due to collateral vessels is blunted. Significantly, the identification of neuroprotective genes such as Msr1 provides new genes for future mechanistic studies of infarction following ischemic stroke and provides novel gene/protein targets for therapeutic development. Author summary: The most common form of stroke arises when a blockage occurs in a blood vessel of the brain, thereby preventing delivery of oxygen and nutrients to areas supplied by the affected vessel, leading to tissue death. The main treatment for this form of stroke is medication to dissolve the blockage; however, more treatment options are required to better reduce the death and disability associated with stroke. In this study, we sought to identify genes that can decrease the amount of damage to brain tissue following a stroke, with a specific focus on examining genes that work to directly protect the neurons, rather than returning blood flow to the affected area. Since it is impossible to precisely control the nature of stroke and the genetic variability in humans, we used mice identify a genetic region that is associated with the amount of tissue damage following stroke. Within this genetic region, we identified a list of candidate genes, including the gene Msr1 , which we found is important for controlling tissue damage in one genetic population of mice after stroke. The genes identified here require further follow-up to determine the impact on stroke outcomes and the usefulness of these candidates as therapeutic targets.
- Open Access
- 1 October 2020
- Published by Oxford University Press (OUP) in Genetics
- Vol. 216  (2) , 585-597
Age and Genetic Background Modify Hybrid Male Sterility in House Mice
Hybrid male sterility (HMS) contributes to reproductive isolation commonly observed among house mouse (Mus musculus) subspecies, both in the wild and in laboratory crosses. Incompatibilities involving specific Prdm9 alleles and certain Chromosome (Chr) X genotypes are known determinants of fertility and HMS, and previous work in the field has demonstrated that genetic background modifies these two major loci. We constructed hybrids that have identical genotypes at Prdm9 and identical X chromosomes, but differ widely across the rest of the genome. In each case, we crossed female PWK/PhJ mice representative of the M. m. musculus subspecies to males from a classical inbred strain representative of M. m. domesticus: 129S1/SvImJ, A/J, C57BL/6J, or DBA/2J. We detected three distinct trajectories of fertility among the hybrids using breeding experiments. The PWK129S1 males were always infertile. PWKDBA2 males were fertile, despite their genotypes at the major HMS loci. We also observed age-dependent changes in fertility parameters across multiple genetic backgrounds. The PWKB6 and PWKAJ males were always infertile before 12 weeks and after 35 weeks. However, some PWKB6 and PWKAJ males were transiently fertile between 12 and 35 weeks. This observation could resolve previous contradictory reports about the fertility of PWKB6. Taken together, these results point to multiple segregating HMS modifier alleles, some of which have age-related modes of action. The ultimate identification of these alleles and their age-related mechanisms will advance understanding both of the genetic architecture of HMS and of how reproductive barriers are maintained between house mouse subspecies.
- 1 October 2020
- Published by Oxford University Press (OUP) in Genetics
- Vol. 216  (2) , 585-597
Open AccessAge and Genetic Background Modify Hybrid Male Sterility in House Mice
Hybrid male sterility (HMS) contributes to reproductive isolation commonly observed among house mouse (Mus musculus) subspecies, both in the wild and in laboratory crosses. Incompatibilities involving specific Prdm9 alleles and certain Chromosome (Chr) X genotypes are known determinants of fertility and HMS, and previous work in the field has demonstrated that genetic background modifies these two major loci. We constructed hybrids that have identical genotypes at Prdm9 and identical X chromosomes, but differ widely across the rest of the genome. In each case, we crossed female PWK/PhJ mice representative of the M. m. musculus subspecies to males from a classical inbred strain representative of M. m. domesticus: 129S1/SvImJ, A/J, C57BL/6J, or DBA/2J. We detected three distinct trajectories of fertility among the hybrids using breeding experiments. The PWK129S1 males were always infertile. PWKDBA2 males were fertile, despite their genotypes at the major HMS loci. We also observed age-dependent changes in fertility parameters across multiple genetic backgrounds. The PWKB6 and PWKAJ males were always infertile before 12 weeks and after 35 weeks. However, some PWKB6 and PWKAJ males were transiently fertile between 12 and 35 weeks. This observation could resolve previous contradictory reports about the fertility of PWKB6. Taken together, these results point to multiple segregating HMS modifier alleles, some of which have age-related modes of action. The ultimate identification of these alleles and their age-related mechanisms will advance understanding both of the genetic architecture of HMS and of how reproductive barriers are maintained between house mouse subspecies.
- Open Access
Age and genetic background modify hybrid male sterility in house mice
Hybrid male sterility (HMS) contributes to reproductive isolation commonly observed among house mouse (Mus musculus) subspecies, both in the wild and in laboratory crosses. Incompatibilities involving specific Prdm9 alleles and certain Chromosome (Chr) X genotypes are known determinants of fertility and HMS, and previous work in the field has demonstrated that genetic background modifies these two major loci. We constructed hybrids that have identical genotypes at Prdm9 and identical X chromosomes, but differ widely across the rest of the genome. In each case, we crossed female PWK/PhJ mice representative of the M. m. musculus subspecies to males from a classical inbred strain representative of M. m. domesticus: 129S1/SvImJ, A/J, C57BL/6J, or DBA/2J. We detected three distinct trajectories of fertility among the hybrids using breeding experiments. The PWK129S1 males were always infertile. PWKDBA2 males were fertile, despite their genotypes at the major HMS loci. We also observed age-dependent changes in fertility parameters across multiple genetic backgrounds. The PWKB6 and PWKAJ males were always infertile before 15 weeks and after 35 weeks, yet some PWKB6 and PWKAJ males were fertile between fifteen and 35 weeks. This observation could resolve previous contradictory reports about the fertility of PWKB6. Taken together, these results point to multiple segregating HMS modifier alleles, some of which have age-related modes of action. The ultimate identification of these alleles and their age-related mechanisms will advance understanding both of the genetic architecture of HMS and of how reproductive barriers are maintained between house mouse subspecies.
Open AccessAge and genetic background modify hybrid male sterility in house mice
Hybrid male sterility (HMS) contributes to reproductive isolation commonly observed among house mouse (Mus musculus) subspecies, both in the wild and in laboratory crosses. Incompatibilities involving specific Prdm9 alleles and certain Chromosome (Chr) X genotypes are known determinants of fertility and HMS, and previous work in the field has demonstrated that genetic background modifies these two major loci. We constructed hybrids that have identical genotypes at Prdm9 and identical X chromosomes, but differ widely across the rest of the genome. In each case, we crossed female PWK/PhJ mice representative of the M. m. musculus subspecies to males from a classical inbred strain representative of M. m. domesticus: 129S1/SvImJ, A/J, C57BL/6J, or DBA/2J. We detected three distinct trajectories of fertility among the hybrids using breeding experiments. The PWK129S1 males were always infertile. PWKDBA2 males were fertile, despite their genotypes at the major HMS loci. We also observed age-dependent changes in fertility parameters across multiple genetic backgrounds. The PWKB6 and PWKAJ males were always infertile before 15 weeks and after 35 weeks, yet some PWKB6 and PWKAJ males were fertile between fifteen and 35 weeks. This observation could resolve previous contradictory reports about the fertility of PWKB6. Taken together, these results point to multiple segregating HMS modifier alleles, some of which have age-related modes of action. The ultimate identification of these alleles and their age-related mechanisms will advance understanding both of the genetic architecture of HMS and of how reproductive barriers are maintained between house mouse subspecies.
- 1 November 2019
- Published by Oxford University Press (OUP) in Genetics
- Vol. 213  (3) , 1079-1092
Novel Neuroprotective Loci Modulating Ischemic Stroke Volume in Wild-Derived Inbred Mouse Strains
To identify genes involved in cerebral infarction, we have employed a forward genetic approach in inbred mouse strains, using quantitative trait loci (QTL) mapping for cerebral infarct volume after middle cerebral artery occlusion. We had previously observed that infarct volume is inversely correlated with cerebral collateral vessel density in most strains. In this study, we expanded the pool of allelic variation among classical inbred mouse strains by utilizing the eight founder strains of the Collaborative Cross and found a wild-derived strain, WSB/EiJ, that breaks this general rule that collateral vessel density inversely correlates with infarct volume. WSB/EiJ and another wild-derived strain, CAST/EiJ, show the highest collateral vessel densities of any inbred strain, but infarct volume of WSB/EiJ mice is 8.7-fold larger than that of CAST/EiJ mice. QTL mapping between these strains identified four new neuroprotective loci modulating cerebral infarct volume while not affecting collateral vessel phenotypes. To identify causative variants in genes, we surveyed nonsynonymous coding SNPs between CAST/EiJ and WSB/EiJ and found 96 genes harboring coding SNPs predicted to be damaging and mapping within one of the four intervals. In addition, we performed RNA-sequencing for brain tissue of CAST/EiJ and WSB/EiJ mice and identified 79 candidate genes mapping in one of the four intervals showing strain-specific differences in expression. The identification of the genes underlying these neuroprotective loci will provide new understanding of genetic risk factors of ischemic stroke, which may provide novel targets for future therapeutic intervention of human ischemic stroke.
- 1 November 2019
- Published by Oxford University Press (OUP) in Genetics
- Vol. 213  (3) , 1079-1092
Novel Neuroprotective Loci Modulating Ischemic Stroke Volume in Wild-Derived Inbred Mouse Strains
To identify genes involved in cerebral infarction, we have employed a forward genetic approach in inbred mouse strains, using quantitative trait loci (QTL) mapping for cerebral infarct volume after middle cerebral artery occlusion. We had previously observed that infarct volume is inversely correlated with cerebral collateral vessel density in most strains. In this study, we expanded the pool of allelic variation among classical inbred mouse strains by utilizing the eight founder strains of the Collaborative Cross and found a wild-derived strain, WSB/EiJ, that breaks this general rule that collateral vessel density inversely correlates with infarct volume. WSB/EiJ and another wild-derived strain, CAST/EiJ, show the highest collateral vessel densities of any inbred strain, but infarct volume of WSB/EiJ mice is 8.7-fold larger than that of CAST/EiJ mice. QTL mapping between these strains identified four new neuroprotective loci modulating cerebral infarct volume while not affecting collateral vessel phenotypes. To identify causative variants in genes, we surveyed nonsynonymous coding SNPs between CAST/EiJ and WSB/EiJ and found 96 genes harboring coding SNPs predicted to be damaging and mapping within one of the four intervals. In addition, we performed RNA-sequencing for brain tissue of CAST/EiJ and WSB/EiJ mice and identified 79 candidate genes mapping in one of the four intervals showing strain-specific differences in expression. The identification of the genes underlying these neuroprotective loci will provide new understanding of genetic risk factors of ischemic stroke, which may provide novel targets for future therapeutic intervention of human ischemic stroke.
- Open Access
Identification of novel neuroprotective loci modulating ischemic stroke volume in a cross between wild-derived inbred mouse strains
To identify genes involved in cerebral infarction we have employed a forward genetic approach in inbred mouse strains, using quantitative trait locus (QTL) mapping for cerebral infarct volume after middle cerebral artery occlusion. We had previously observed that infarct volume is inversely correlated with cerebral collateral vessel density in the strains. In this study, we expanded the pool of allelic variation among classical inbred mouse strains by utilizing the eight founder strains of the Collaborative Cross and found a wild-derived strain, WSB/EiJ, that breaks this general rule that collateral vessel density inversely correlates with infarct volume. WSB/EiJ and another wild-derived strain, CAST/EiJ, show the highest collateral vessel densities of any inbred strain, but infarct volume of WSB/EiJ mice is 8.7-fold larger than that of CAST/EiJ mice. QTL mapping between these strains identified four new neuroprotective loci modulating cerebral infarct volume while not affecting collateral vessel phenotypes. To identify causative variants in genes we surveyed non-synonymous coding SNPs between CAST/EiJ and WSB/EiJ and found 96 genes harboring coding SNPs predicted to be damaging and mapping within one of the four intervals. In addition, we performed RNA sequencing for brain tissue of CAST/EiJ and WSB/EiJ mice and identified 79 candidate genes mapping in one of the four intervals showing strain-specific differences in expression. The identification of the genes underlying these neuroprotective loci will provide new understanding of genetic risk factors of ischemic stroke which may provide novel targets for future therapeutic intervention of human ischemic stroke.
Open AccessIdentification of novel neuroprotective loci modulating ischemic stroke volume in a cross between wild-derived inbred mouse strains
To identify genes involved in cerebral infarction we have employed a forward genetic approach in inbred mouse strains, using quantitative trait locus (QTL) mapping for cerebral infarct volume after middle cerebral artery occlusion. We had previously observed that infarct volume is inversely correlated with cerebral collateral vessel density in the strains. In this study, we expanded the pool of allelic variation among classical inbred mouse strains by utilizing the eight founder strains of the Collaborative Cross and found a wild-derived strain, WSB/EiJ, that breaks this general rule that collateral vessel density inversely correlates with infarct volume. WSB/EiJ and another wild-derived strain, CAST/EiJ, show the highest collateral vessel densities of any inbred strain, but infarct volume of WSB/EiJ mice is 8.7-fold larger than that of CAST/EiJ mice. QTL mapping between these strains identified four new neuroprotective loci modulating cerebral infarct volume while not affecting collateral vessel phenotypes. To identify causative variants in genes we surveyed non-synonymous coding SNPs between CAST/EiJ and WSB/EiJ and found 96 genes harboring coding SNPs predicted to be damaging and mapping within one of the four intervals. In addition, we performed RNA sequencing for brain tissue of CAST/EiJ and WSB/EiJ mice and identified 79 candidate genes mapping in one of the four intervals showing strain-specific differences in expression. The identification of the genes underlying these neuroprotective loci will provide new understanding of genetic risk factors of ischemic stroke which may provide novel targets for future therapeutic intervention of human ischemic stroke.